More Robert J
Director at TYRA; Director at VIR; Other at ALLK, and 6 more
- Sold, on record
- $30.9M
- Dollars the filings state
- Form 4 sales
- 22
- Latest Dec 19, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 9
- Filed as an executive or holder
Companies
- TYRATyra Biosciences, Inc.Director
- VIRVir Biotechnology, Inc.Director
- ALLKAllakos Inc.Other
- Sienna Biopharmaceuticals, Inc.Director
- Volcano CORP10% owner
- Orexigen Therapeutics, Inc.10% owner
- NOVACEA INC10% owner
- Somaxon Pharmaceuticals, Inc.10% owner
- VNDAVanda Pharmaceuticals Inc.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Volcano CORP961,608 shares
- TYRA256,871 shares
- VIR88,478 shares
- ALLK44,092 shares
- NOVACEA INC24,500 shares
- Sienna Biopharmaceuticals, Inc.24,429 shares
- Orexigen Therapeutics, Inc.21,000 shares
- Somaxon Pharmaceuticals, Inc.12,918 shares
- VNDA12,900 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale VIRPlan not statedMay 20 2021
Sold 11,670 shares at $44.51 ($519k)
More Robert J, Director
Sold 11.6% of holdings ($4.5M position)89,335 shares leftFiling
- 2 Form 4 sale VIRPlan not statedJun 3 +14 days
Sold 11,670 shares at $44.56 ($520k)
More Robert J, Director
Sold 12.6% of holdings ($4.1M position)81,039 shares leftFiling
- 3 Form 4 sale VIRPlan not statedJun 17 +14 days
Sold 11,670 shares at $43.95 ($513k)
More Robert J, Director
Sold 14.4% of holdings ($3.6M position)69,369 shares left1x usual sizeFiling
- 4 Form 4 sale VIRPlan not statedJul 1 +14 days
Sold 11,670 shares at $44.93 ($524k)
More Robert J, Director
Sold 16.8% of holdings ($3.1M position)57,699 shares left1x usual sizeFiling
- 5 Form 4 sale VIRPlan not statedJul 15 +14 days
Sold 11,670 shares at $35.56 ($415k)
More Robert J, Director
Sold 20.2% of holdings ($2.1M position)46,029 shares left1x usual sizeFiling
- 6 Form 4 sale VIRPlan not statedJul 29 +14 days
Sold 11,670 shares at $36.82 ($430k)
More Robert J, Director
Sold 24.5% of holdings ($1.8M position)36,030 shares left1x usual sizeFiling
- 7 Form 4 sale TYRARoutineNov 21 +1576 days
Sold 246,871 shares at $20.25 ($5M)
More Robert J, Director
10b5-1 planSold 6.1% of holdings ($82.6M position)3.8M shares leftFirst sale on recordFiling
- 8 Form 4 sale TYRARoutineDec 19 +28 days
Sold 10,000 shares at $25.00 ($250k)
More Robert J, Director
10b5-1 planSold 0.3% of holdings ($95.8M position)3.8M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (22)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | TYRA | Director | Form 4 sale | 10,000 | $250k | 0.3% | Routine | SEC |
| Nov 21, 2025 | TYRA | Director | Form 4 sale | 246,871 | $5M | 6.1% | Routine | SEC |
| Jul 29, 2021 | VIR | Director | Form 4 sale | 11,670 | $430k | 24.5% | Plan not stated | SEC |
| Jul 15, 2021 | VIR | Director | Form 4 sale | 11,670 | $415k | 20.2% | Plan not stated | SEC |
| Jul 1, 2021 | VIR | Director | Form 4 sale | 11,670 | $524k | 16.8% | Plan not stated | SEC |
| Jun 17, 2021 | VIR | Director | Form 4 sale | 11,670 | $513k | 14.4% | Plan not stated | SEC |
| Jun 3, 2021 | VIR | Director | Form 4 sale | 11,670 | $520k | 12.6% | Plan not stated | SEC |
| May 20, 2021 | VIR | Director | Form 4 sale | 11,670 | $519k | 11.6% | Plan not stated | SEC |
| Mar 5, 2021 | ALLK | Other | Form 4 sale | 32,554 | $3.7M | 100.0% | Unusual | SEC |
| May 18, 2020 | ALLK | Other | Form 4 sale | 11,538 | $826k | 100.0% | Unusual | SEC |
| May 1, 2020 | VIR | Director | Form 4 sale | 18,458 | $517k | 20.5% | Plan not stated | SEC |
| Mar 29, 2018 | Sienna Biopharmaceuticals, Inc. | Director | Form 4 sale | 24,429 | $459k | 12.0% | Plan not stated | SEC |
| Jul 16, 2008 | Volcano CORP | 10% owner | Form 4 sale | 15,655 | $227k | 20.0% | Plan not stated | SEC |
| Apr 8, 2008 | Volcano CORP | 10% owner | Form 4 sale | 13,613 | $177k | 14.8% | Plan not stated | SEC |
| Nov 27, 2007 | Orexigen Therapeutics, Inc. | 10% owner | Form 4 sale | 21,000 | $300k | 20.0% | Plan not stated | SEC |
| Jun 6, 2007 | NOVACEA INC | 10% owner | Form 4 sale | 24,500 | $276k | 25.0% | Plan not stated | SEC |
| May 31, 2007 | Volcano CORP | 10% owner | Form 4 sale | 22,230 | $447k | 100.0% | Unusual | SEC |
| May 18, 2007 | Volcano CORP | 10% owner | Form 4 sale | 20,419 | $393k | 18.2% | Plan not stated | SEC |
| Dec 21, 2006 | Somaxon Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 6,459 | $87k | 25.0% | Plan not stated | SEC |
| Dec 12, 2006 | VNDA | 10% owner | Form 4 sale | 12,900 | $330k | 38.0% | Unusual | SEC |
| Dec 6, 2006 | Volcano CORP | 10% owner | Form 4 sale | 889,691 | $14.9M | 88.8% | Unusual | SEC |
| Sep 18, 2006 | Somaxon Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 6,459 | $84k | 20.0% | Plan not stated | SEC |